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ABSTRACT 
 
     We analyzed in vitro expansion and differentiation of T progenitor cells from umbilical cord blood in 
the absence of thymic epithelium. The expansion setup is performed in the presence of SCF, IL-7 , and IL 
-2 with autologous serum .Using CBMCs as initial source , we compared the growth kinetics of several 
cell populations in either whole CBMC or  CD34+ -enriched-, as well as in CD3CD4CD8-depleted 
expansion assays by FACS analysis. After 11 days of culture, cell increase values were about 7 fold for 
CD3+, 6 fold for CD3+CD4+, 7 fold for CD3+CD8+, 4fold for CD3+CD56, 6fold for CD56+, and 0.2 
fold for CD34+. We characterized the developmental state of these cell populations by RT –PCR analysis 
of the lymphoid differentiation markers RAG-1 and pre T-Alpha. In all samples , transcripts of both 
markers could be detected from day 0 though day 11, however , in case of pre – T-Alpha,  nested PCR  
was always required , indicating lower expression . These findings; therefore, demonstrate that T-cell 
differentiation events (as opposed to mere expansion) do occur in stroma cell free expansion assays. 
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INTRODUCTION 
     Human umbilical cord blood (CB) is an 
alternative source to marrow for expansion of 
progenitor cells [1-2]. Mature T cells in CB are 
mostly resting [3]. The content of CD34+ 
progenitor cells in CB is approximately 0.4%. 
The common protocols for expanding progenitor 
cells into T cells from different sources always 
require the presence of thymic stroma layer [5-
7], e.g. fetal thymic organ culture (FTOC) is a 
well defined system for the expansion and 
lymphopoiesis of T cells [8-10]. Generally, for T 
lymphopoiesis progenitor cells have to migrate 
through the thymus by expressing specific 
surface markers such as CD2, CD7, CD3, CD4, 
CD8, and the T cell receptor (TCR). The 
chronological order of expressing these surface 
antigens is briefly from CD3-CD4-CD8- (triple-
negative, TN) to low CD4+ and to the double –
positive (DP, CD4+ CD8+) stage. These DP 
cells undergo the positive and negative selection 
and will be finally single – positive (CD+, or 
CD8+, SP) with concomitant expression of the 
TCR. In mouse cells the TN stage is well 
defined through the alternate expression CD25 
and CD44. They express successively CD25-
CD44+, CD25+CD44- and finally CD25- and 
CD44- [11-13]. The branch point of lineage 
separation (TCRαβ versus TCRγδ positive T 
cell) is at the TN CD25+CD44- stage. The 
rearrangements of TCR genes start with 
transcription of RAG -1 (recombination 
activating gene) and RAG-2, which 
synergistically cut the DNA [14]. During this 
phase the TCRβ and the pre-Tα chains are co-
expressed and form the pre TCR [15-17]. From 
this time of the thymocytes become DP and the 
thymic selection process begins. Mature SP 
CD3+TCRαβ +thymocytes do not express pre 
Tα or RAG-1/2 anymore, and are able to migrate 
out of the thymus.  
     So far, all these developmental steps and their 
regulation have not been completely understood; 
some developmental events are under control of 
some cytokines such as IL -7(Interleukin-7) IL-7 
is necessary for the activity of RAG proteins 
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during the recombination of sub-genic elements 
of the respective TCR chain [18]. More 
immature T progenitors are CD34+ and express 
the c-kit (CD117) receptor. These cells can be 
activated through stem cell factors (SCF) and are 
than able to undergo further differentiation. 
Interestingly, activation through IL-2 does not 
seem to be necessary, because in IL -2 knockout 
mice mature T cells could be detected [19]. 
However, IL-2 is discussed as a possible 
inhibitor of myelopoisis (A.R.M, unpublished 
results). 
     Extrathymic differentiation of T cells is 
shown for intraepithelial lymphocytes (IELs) in 
the gut [20]. This kind of differentiation 
produces also mature T cells, but some distinct 
cell populations such as DN TCRαβ+, CD8αα 
and TCRγδ T cells show a higher increase [21]. 
It is not completely known, however, if this kind 
of T cell development is totally independent 
from the thymus, since it is conceivable that 
soluble factors from the thymus can drive the 
differentiation of these cells [22]. 
     In the present study we demonstrate that T 
cell expansion with SCF, IL-7, and IL-2  from 
human umbilical cord blood is a suitable system 
for generating mature functional T cells. We 
assume that expansion of T progenitor cells and 
T cells include both proliferation and T 
lymphopoiesis. We; therefore, analyzed 
temporarily expressed genes, required for T cell 
maturation such as RAG-1 and pre-Tα. 
Expression of these genes demonstrates that 
immature T cells are in the developmental phase 
recombining their TCRs. 
 
MATERIAL AND METHODS 
  
Collection of umbilical cord blood 
     Cord blood was collected into 150 ml 
collection bags (MS22204Q; Macopharma, 
Langen, Germany ) containing 21 ml citrate- 
phosphate dextrose (CPD) as anticoagulant in 
the Obstetric Departments with the informed 
consent of the mother . 
 
Isolation of mononuclear cells  
     Cord blood was sedimented (1500 rpm, 5 
 min), the serum supernatant was preserved, 
inactivated (56 C, 30 min) and filtered (0.4 μm 
sterile filter , Sartorius , Gottingen Germany). 
The buffy coat was put on a ficoll gradient 
(Seromed Ficoll Separating Solution, Biochrom, 
Berlin, Germany), and centrifuged (1800  rpm , 
10 min). Later on, the mononuclear cells were 
isolated and washed twice in PBS (Serag-
Wiessner, Naila, Germany). Erythrocyte lysis 
was done with 5 ml Ammoniumchloride 
(containing 0,3g NH4Cl, 1g KHCO3, 0.0375g 
Na-FDTA per liter) and 20 ml PBS for 10 min at 
4º C so that the cells were sedimented as 
described above and re-suspended in PBS. Cell 
count was performed with a hemocytometer and 
additionally with the CellDyn 3500 analyzer 
(Abbott, Wiesbaden, Germany). 
 
Freezing and thawing of cord blood  
     Pellets form cord blood samples were re-
suspended in ice-cold freezing medium (65% Ex 
vivo 10 (Biowhitaker, Walkersville, USA), 10% 
Dimethylsulfoxide (Sigma, Deisenhofen, 
Germany) 25% inactivated and filtered 
autologous serum, which is diluted 1/10 with 
CPD as anticoagulant). Thawing of CB samples 
was performed as described by Rubinstein et al, 
[23]. 
 
Enrichment of CD34+ progenitor cells  
     CD34+ cells were separated from CB 
mononuclear cells (according to the instruction 
of the manufacturer) with the CD 34 /Magnetic. 
Activated Cell Sorting isolation system (MACS, 
Miltenyi Biotec, Bergisch Gladbach, Germany), 
equipped with VS+ separation columns. The 
purity was analyzed with cytoflourometry after 
staining with CD34+ antibody. 
 
Depletion of T cells  
     T cells were depleted with CD3-, CD4-, and 
CD8- MACS-beads at once with the previously 
described MACS isolation system using VS- 
columns. The purity of depletion was quantified 
by cytofourometry after staining with anti-
TCRαβ andtibody. 
 
Cell lines and thymocytes  
     The immature T cell line Molt -3 was used as 
a control for RAG-1 gene expression [24]. On 
the other hand, we used Thymocytes served as 
control for RAG-1 andpre – Tα expression [25]. 
Ex vivo expansion of mononuclear cells, CD34+ 
progenitor cells, and T cell depleted cells.  
For expansion, cells were cultured 10-11 days in 
Ex vivo 10 medium supplemented with 15% 
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autologous serum. The following factors are 
added: 10 ng/ml SCF (StemCell Technologies, 
Vancouver, Canada), 10 ng/ma IL-7 (Genzyme, 
Russelsheim, Germany), and 100 U/ml IL-2 
(proleukin, Chiron, Ferwald, Germany) in 24 
well plates (Costar, Cambridge, MA, USA). 
     Cell counts are preformed at day 0, 4, 8 and 
10/11. The initial concentration was 1 ×10 5 for 
CBMCs and CD3-CD4-CD8- cells and 2 ×10 5 
c/ml for the CD34+ cell population. 
 
Analysis of surface markers by flow 
cytometry  
     Monoclonal antibodies (MoAbs) specific for 
the following markers were used: CD3, CD4, 
CD8, CD34, CD45, CD45RO,  CD45RA, CD56, 
CD117, TCRαβ, TCRγδ were conjugated 
antibodies directed to CD34, CD45RA, CD4, 
CD8, CD3, CD45RO, TCRγδwere obtained 
from Coulter Immunotech (Hamburg, Germany) 
PE –conjugated antibodies are specific for CD4, 
CD117, TCRαβ (coulter Immunotech), and 
CD56 (pharmingen) cychrome conjugate 
MoAbs to CD45, CD4, CD3 were obtained from 
Coulter Immunotech, MACS-CD3-Microbeads 
from Miltenyi Biotech (Bergisch Gladbach, 
Germany) and were used to swparate cell 
suspensions . Determination of cell surface 
antigens was performed on a cell analysis / 
sorting unit from Coulter, which is equipped 
with an argon ion laser and a helium neon laser. 
Three color analyses with cord blood cells were 
gated on lymphocytes with exclusion of cell 
debris. Analysis of cells for expression of cell 
surface antigens was achieved with data 
acquisition research software (Coulter). The 
γ1/γ1 IgG control antibody (Becton- Dickinson, 
Erembodegem – Aalst, Belgium) was used for 
the same cells and also propidium iodide was 
added to detect dead cells. 
 
cDNA synthesis and polymerase chain 
reaction  
     Total RNA was isolated from 1 ×10 5 cells 
with the RNeasy Kit according to the 
manufactures description (Qiagen, Hilden, 
Germany). About 500 ng of total RNA was 
added to the cDNA  synthesis reaction using the 
following protocol: 6 μ1 of 5 × buffer (Promega, 
Madison, USA), 20U  of RNAsin (promega, 
Madison, USA), 100 pmol of random hexamer 
primers (Pharmacia, Uppsala, Sweden (2 μ1 of 
dNTP solution (10 mM each, Pharmacia, 
Uppsala, Sweden) and 9 U AMV Reverse 
Transcriptase (Promega, Madison, WI, USA) 
filled up with water to a final reaction volume of 
30μ1. The reaction mixture was incubated at 42 
C for 45 min. Afterwards, the reaction was 
terminated by heating 5 min 95º C and then 
quick cooled on ice. The cDNA was used 
afterwards for the PCR reaction, or stored at -
20° C. PCR reaction mixture: 1 to 10 μ1 cDNA 
reaction mixture (1 μ1 for GAPDH, 10 μ1 FOR 
RAG-1, and pre –Tα) 10×PCR buffer (Gibco 
BRL, Gaithersburg, USA), 0.2 mM of dNTP, 50 
pmol of each primer, 2 U of Taq DNA 
polymerase (Gibco BRL, Gaithersburg, USA). 
Water was added to 100 μ1 reaction volume. 
Amplifications were carried out with a thermal 
cycler (GeneAmp PCR system 2400, Perkin 
Elmer, Norwalk, USA). The following profile 
over 35 cycles was performed: 3 min 94C for the 
first delay, 30 sec at 94º C for denaturation, 30 
sec at 59º C for annealing, 30 sec at 72C for 
extension, and the last delay at 10 min 72º C .10 
μ1 of the PCR reaction mixture were 
electrophoresed through 2% agarose gels stained 
with ethidium bromide and visualized under UV 
light. The following primers were used: RAG15 
-5’-GAA CAC ACT TTG CCT TCT CTT TGG-
3’ RAG-1 3’ |5’ –GTC CAG CCC TAC CCA 
CAG GTG T-3 ‘: pre Tα5’:5’ –GTC CAG CCC 
TAC CCA CAG GTG T-3’pre-Tα3’:5-CGG 
GAA TTC GAC GTC CCT GGC TGT AGA 
AGC CTC TC-3’ pre –Tα-nested 5’:5-TCT 
GGC CCC ACC AAT CAT GC-3’,Pre-Tα-
nested3.’5-TGT ACT CCT GCT GTG AG-
3.GAPDH5.5-ACG GAT TTG GTC GTA TTG 
GGC G-3,GAPDH3.5-CTC CTG GAA GAT 
GGT GAT GG-.3 
     Confirmation of PCR products using cycle 
sequencing with flourophor labeled primers 
Sequencing was preformed with the sequencing 
kit according to the protocol of the manufacturer 
(Thermo Sequenase fluorescent labelled primer 
cycle sequencing kit with 7- deaza-dGTP , 
Amersham Life Science , Buckinghamshire , 
England ).using flourophor labelled primers 
(MWG ,Ebersberg,Germany).An infrared 
fluorescence technology (DNA sequencer  
model DNA4000L,LI-COR,Lincoln ,USA) was 
used for the detection of the sequencing 
products. 
 
Journal of Paramedical Sciences (JPS)                     Summer 2010 Vol.1, No.3 ISSN 2008-496X 
   __________________________________________________________________________________________________________________                  
 
45 
 
RESULTS  
     Growth kinetics of CB mononuclear cells, 
CD34+ enriched progenitor cells and T cell 
depleted cells. 
The used expansion system was designed to 
show de novo generation of T lymphocytes and 
not for the highest increase in cell number. The 
main criterion for expansion of cells is the 
general increase in cell densities. The chief 
characteristic of this study is the production of T 
helper cells from mononuclear cells.  To 
compare the obtained data with different cell 
populations for expansion, we used T lineage 
depleted cells (CD3-CD4-CD8-) and CD34+ 
progenitor cells to demonstrate any differences 
and dependency or independence of the specific 
cell populations form each other. CB-MNC 
grow from 1×10 5 up 7×10 5 c/ml during 11 
days of culture (all mean values, n=8) .In 
contrast, CB CD34+ cells grow from the initial 
density 1, 4×10 5 to 2, 6×10 5 c/ml during 10 
days of culture (n=2). Depleted cells (CD3-
CD4-CD8-cells) don’t increase in cell number 
(n=2), but decrease form 1×10 5 c/ml to 4×10 4 
c/ml during 11 days of culture (Figure1).  
 
 
 
 
Figure 1. Kinetics of ex v ivo expansion of CBMCs in the presence of SCF, IL-7, and IL-2 over 10 days (CD34+) and 11days 
(CBMCs, CD3-CD4-CD8-cells). The results of eight (CBMCs) and two (CD3-CD4CD8-and CD34+cells) experiments are 
expressed as mean ±SD for total cell growth. 
 
Phenotype analysis and growth of ex vivo 
expanded T and NK cells  
      We counted the cells of relevant populations 
for T and NK cell development, for instance 
CD3+Cd4+ (T helper cells), CD3+CD8 
(cytotoxic T cells), and all T cells which are 
CD3+, respectively TCRαβ+ (Figure 2). The 
increase value in CBMC culture for TCRαβ+ 
cells is 6. 4 fold, T helper cells (CD3+CD4+) 
increase 6 fold and cytotoxic T cells 
(CD3+CD8+) increase 7 fold. In general, all 
CD3+ cells including CD3+ CD56+ cell (4 fold 
increases) show an increase 6. 9 fold. NK cells 
(CD56+) which are CD3- increases 6 fold in 
MNC culture. CD34+ cells, which represent the 
progentitors for T cells are undergoing decrease 
to 0.2 fold. Increase values of T helper cells 
(CD3+CD4+), cytotoxic T cells (CD3+CD8+), 
all CD3+ cells (mainly mature T cells ), 
TCRαβ+cells ( all mature T cells), a 
subpopulation of NK cells (CD3+CD56+), all 
NK cells (CD56+), and progenitor cells (mainly 
CD34+ cells), after expansion of CBMCs. Six 
experiments with independent donors are 
expressed as mean ± SD (day 0 is set to 1) (B) 
Expansion of T cell depleted cells (CD3-CD4-
CD8-) after 11 days illustrated as increase 
values. The main T cells (CD3+TCRαβ+) 
population was compared with NK cells 
(CD3+CD56+and CD56+) and progenitor cells 
(CD34+). The results of two experiments with 
independent donors are expressed as mean±SD 
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(day 0 is set to 1). (C) Increase of T/NK cell 
populations from CD34+ enriched cell culture 
after 10 days in the presence of SCF, IL -7, and 
IL-2. ,   Two expansion assays were done with 
CD34+ cells from independent donors and the 
increase values are expressed as mean±SD for 
each cell population (day0 is set to 1) . 
     To answer the question if this cell population 
can develop independently from each other, a 
depletion experiment with CD3+, CD4+, and 
CD8+ antibodies was performed, which mainly 
deplete the mature T cell population. 
Interestingly, this time T cells only show a low 
increase, e.g. the TCRαβ+cells 1.7 fold on 
average (Figure 2b). NK cells (all CD56+ cells) 
show an increase about 30 fold and the 
CD3+CD56+NK-Subopulation 15 fold. 
     This finding demonstrates that depletion of 
CD3+, CD4+ and CD8+ cells efficiently prevent 
progenitor cells to develop into mature T cells. 
In contrast, the high increase of NK cells 
suggests their independent development from T 
cells and other CD4+ and CD8+ cells. 
     The CD34+ selected fraction (purity>96%) 
show a dramatic decrease in CD34 cells (0.01 
fold)followed by 10.3 fold increase of CD3+ 
cells after 10 days of culture (Figure 2c). These 
results suggest that CD34+progenitor cells 
differentiate under the described conditions into 
mature T cells. The CD56+ NK cells expand 6.4  
fold, which is nearly identical with the obtained 
results from CBMCs, however, the 
CD3+CD56+  NK subpopulation increases only 
1.5 fold (CB-MNCs 4fold). 
 
 
 
 
  
 
 
 
 
 
Figure 2. (a) Increased values of mature T 
Cells, NK cells, Progenitor cells from CBMCs 
in day 0 and 10/11 (b) Expansion of T cells 
depleted cells after 11 days illustrated as 
increase value. The comparison of different 
increase value in T cells, NK cells and 
progenitor cells on day 0 to 11 (C) Increase 
values of T NK cell culture after 10 days. 
 
Amplification of RAG-1 and pre-Tα 
transcripts in ex vivo culture  
     To demonstrate the developmental stage of T 
progenitor cells (conversion of TN to DP cells) a 
RT-PCR analysis of RAG-1 and pre – Tα 
transcripts was performed, since mature T cells 
do not transcribe these temporarily expressed 
genes. Kinetics of lymphoid gene expression 
from CBMCs (A and B) after 0, 4, 8, and 11 
days of culture and from CD34+ cells (C) after 0 
and 10 days in presence of SCF , IL -7, and IL-
2. Total RNA was extracted from cells from 4 
experiments with independent CB donors, 
pooled in equal amounts (1μg of total RNA ) 
and subjected to PCR using sequence –specific 
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primers for RAG-1(A and C,b), and pre Tα 
(B,b). Five separate replicate PCR reactions 
were performed for each primer set. Bands of 
expected size were detected for RAG-1; no 
amplified transcripts could be visualized for pre-
Tα in the first PCR. After the second PCR with 
nested primer set, the expected amplification 
products were detected for pre-Tα too. The weak 
signals for pre –Tα thymus control were 
intensified by southern blotting with a sequence 
–specific probe (B,a). For each primer set, a 
simultaneously run template –free PCR reaction 
was used as a negative control. Human thymus 
total RNA (for RAG-1 and pre –Tα ) and total 
RNA from the ALL cell line Molt -3 (only for 
RAG-1) was used as positive controls to confirm 
successful PCR reactions. RAG-1 PCR products 
were also confirmed with southern blotting 
using sequence –specific primers (C,a). 
Amplification of GAPDH confirmed the 
presence of mRNA in all PCR reactions (data 
not shown) .All PCR products were confirmed 
by sequencing. 
During the 10-11 days of cell expansion culture 
the half of the cells (from 1 ml culture) were 
taken for RT-PCR analysis on day 0, 4, 8, and 
11, and pooled from 4 independent donors. 
Monouclear cells from CB show a RAG-1 
amplification product at day 0 until 11 at any 
day of measurement (Figure 3A). This finding 
indicates the permanent developmental status of 
the lymphocytes in this ex vivo expansion 
system. GAPDH control shows the same 
intensity in each sample (data not shown). The 
pre-Tα transcripts are identified as well also 
performing nested PCR, which is due to very 
low expressed status in developing T cell 
progenitors (Figure 3B). 
  
 
 
Figure 3. (A) Kinetics of lymphoid gene expression in CBMCs after 0, 4, 8, and 11 days of culture and from CD34+ cells. 
Total RNA extracted from human thymus to detect RAG-1 in PCR (a,b) Detect ion of pr Tα gene from CB(RNA- extract) to 
perform nested PCR(day to day 11) 
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DISCUSSION  
     The present study has demonstrated that T 
cell expansion in presence of SCF, IL-7 and IL-2 
during 10 or 11 days is an efficient way to 
obtain mature T, and NKcells from CBMCs 
CD3- CD4-CD8-cells are not or only poorly able 
to develop into mature T cells in this expansion 
system, but the capacity to develop into NK cells 
in the absence of CD3, CD4 and CD8 was not 
impaired. The main goal in every T cell 
expansion system is to show the development of 
T cells (as opposed to mere expansion) which so 
far has always required the presence of thymic 
stroma cells such as FTOCs [25-26]. In a 
postulate extrathymic lymphopoiesis event, it 
has to be demonstrated that the same genes are 
temporarily expressed than in thymic 
development. 
     Therefore we have analyzed the expression of 
RAG-1, which is expressed in pre –T and pre –B 
cells, and pre – Tα, which occurs only in 
immature developing T cells [27-28]. RAG-1 
cuts the genomic DNA for V-(D)-J 
rearrangements of TCR genes synergistically 
with RAG-2 and is expressed during the 
selection of immature T cells, whose auto-
reactive potential has been confirmed [29].  
     In this stage the pre-Tα chain functions as a 
surrogate for TCRα and these immature cells 
(mainly DP) undergo further differentiation into 
SP mature T cells [30]. This differentiation step 
takes 24-96 h [31]. Our CBMC-expansion assay 
shows by means of RT-PCR a RAG-1 signal at 
day 0 which persists until day 11. For this reason 
it could be assumed that RAG-1 expressing cells 
that day 0 undergo further differentiation into 
mature cells and the persisting expression comes 
from cells, which newly enter the stage of 
recombining their V(D)J genes. According to 
this hypothesis CD34+ should have been 
decreased during this time. It is known that 
CD34+cells have the potential to differentiate 
into mature T cells under conditions of thymic 
microenvironment [32]. 
     Therefore, we analyzed the CD34+ content in 
CBMCs and in CD34+ expansion assays. In 
CBMC cultures CD34+  cells decrease 5 fold  
over 11 days which is supportive for the 
generation of RAG-1+ cells over the whole 
period of time. It should be pointed out, 
however, that the possibility of arrested RAG-1 
expressing cells and not be excluded. Separated 
CD34+ cells (purity>96٪) express a very faint 
signal for RAG1 at day0, whereas at day 10 the 
amplification product for RAG-1 is clearly 
visible (Fig .X). This indicates the 
differentiation status of cells undergoing 
lymphopoiesis. 
It has been described previously that CD34+ 
cells are still negative for RAG-1 [33]. However, 
we suppose that our finding is due to 
contaminating CD34- cells (approximately 3-4% 
on average) in the CD34+ preparation. The 
small amount of RAG-1 mRNA produced by 
these contaminance could have been amplified 
with the highly sensitive RT-PCR method. 
     The total increase of CD3+ cells form 
enriched CD34+ cells from  enriched CD34+ 
population is 5.6 fold which is comparable to 
corresponding increase in CBMCs (6.9 fold). 
We expected a greater T cell expansion from 
CD34+ cells than from CBMCs, considering the 
very low CD34 + cell content is in the CBMC 
preparation. Our findings, however, may suggest 
that unlike CBMCs, CD34+ cells require 
additional cell population or differentiation 
factors for undergoing lymphopoiesis with the 
use cytokine combinations. Interestingly, 
thymocytes which are CD4+CD8+ can undergo 
conversion into CD4+ or CD8+ T cells without 
thymic epithelium, however, only in the 
presence of expressed surface makers like CD2, 
CD5, CD, CD28,CD49d, CD81, andTSA-1[34]. 
Cell populations which contain these markers 
are; therefore, essential for the final step from 
DP to SP differentiation. Many of these cells 
were removed during the applied CD3, CD4, 
and CD8 depletion step. This could be a possible 
explanation for the absence of the absence of 
mature SP T cells in T cell depleted culture and 
for the low increase in T cell markers in CD34+ 
preparations. 
     The highest increase for NK and CD3+ NK 
cells was observed in the CD3-CD4-CD8-
population. This finding suggests that the 
depletion step has removed possible competitors 
for growth factors. Another explanation could be 
that after depletion no potential inhibitory 
signals were available any longer from CD3, 
CD4, or CD8 carrying cells. 
     The performed experiments have shown that 
the used expansion procedure could be useful for 
the in vitro generation of T and NK cells; these 
generated cells could then be a suitable source 
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for clinical applications, such as the 
reconstitution of the T/NK cell repertoire of 
patients, which are suppressed for immune 
responses after transplantation, as well as for 
cell and gene therapy strategies. 
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